Clinical Trial Update: Assessment of Loading With the P2Y12 Inhibitor Ticagrelor or Clopidogrel to Halt Ischemic Events in Patients Undergoing Elective Coronary Stenting [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing loading with ticagrelor or clopidogrel to prevent ischemic events in patients undergoing elective coronary stenting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Myocardial Ischemia

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Coronary Artery Disease, Myocardial Ischemia | Phase 3 | Status: COMPLETED